Daily BriefsMost Read

Most Read: Douzone Bizon, Kunlun Tech, Bumi Resources Minerals Tbk, Jindal Steel & Power, Toshiba Corp, Thai Life Insurance, Ventia, Ecopro BM Co Ltd, Hong Kong Hang Seng Index, BNC Korea and more

In today’s briefing:

  • KRX New Deal Index Rebalance Preview: Potential & Close Changes in September
  • Index Rebalance & ETF Flow Recap: KS200, KQ150, HSI, CSI300/500, STAR50, SSE50, ChiNext, PCOMP, HDFC
  • LQ45 Index Rebalance Preview (July): Identifying Potential Changes
  • NIFTY100 Index Rebalance Preview: Double/Triple Whammy for Some Stocks
  • Toshiba (6502) – Thinking About the Arb
  • SET50 Index Rebalance Preview: Two Changes – One High Probability; One Has Possibilities
  • Ventia (VNT AU) – Placement Could Lead to ASX200 Inclusion in June
  • Insiders Sell at Ecopro BM
  • EQD | Volatility Update: Weekly Review of Vol Changes and Best Trades- Peak Rates?
  • BNC Korea (256840 KS): Margin Pressure; Base Business Faces Regulatory Risk; COVID Drug in Doldrum

KRX New Deal Index Rebalance Preview: Potential & Close Changes in September

By Brian Freitas

  • The review period for the September rebalance ends on 31 July, the changes will be announced towards end August and implemented at the close of trading on 7 September.
  • There are potential changes to some of the indices and then there are close changes that will result in big flows if they eventuate.
  • The March rebalance saw some funky moves on the stocks that had big flows and we could see more of that at the September rebalance.

Index Rebalance & ETF Flow Recap: KS200, KQ150, HSI, CSI300/500, STAR50, SSE50, ChiNext, PCOMP, HDFC

By Brian Freitas

  • Friday marked the end of the review cutoff for the MSCI, CSI300, CSI500, STAR50, SSE50, ChiNext and a bunch of other indices for the upcoming rebalances in May and June.
  • There are no major index events coming up this week as a lot of markets are shut on different days.
  • There were big inflows to mainland China ETFs during the week, while there was a big redemption from the iShares MSCI ACWI ETF (ACWI US)


NIFTY100 Index Rebalance Preview: Double/Triple Whammy for Some Stocks

By Brian Freitas

  • Halfway through the review period, we see 5 potential changes for the Nifty Next 50 Index (NIFTYJR INDEX)/ Nifty 100 Index (NSE100 INDEX) at the September rebalance.
  • All the potential adds are expected to migrate from MidCap to LargeCap at the AMFI June reclassification, while we expect two of the potential deletes to move the other way.
  • Of the potential deletes, one is a high probability deletion from the MSCI India Index at the May QCIR while there is another that is a lower probability deletion.

Toshiba (6502) – Thinking About the Arb

By Travis Lundy

  • Toshiba is trading at a 12-13% annualised return on the arb when using the expected Tender Offer Start Date proposed in the Takeover Announcement on 23 March 2023.
  • On Day 1-2 post-announcement, Toshiba traded at an 11-13% annualised spread. Since the announcement, a 12-name Peer Basket is up 11+% meaning Toshiba back end risk has shrunk.
  • Forward consensus EPS ratios have fallen, in part due to the shift forward one fiscal year by comps. We’ll see where those lie in a week when earnings come.

SET50 Index Rebalance Preview: Two Changes – One High Probability; One Has Possibilities

By Brian Freitas


Ventia (VNT AU) – Placement Could Lead to ASX200 Inclusion in June

By Brian Freitas


Insiders Sell at Ecopro BM

By Douglas Kim

  • It was recently reported that Choi Mun-Ho (CEO of Ecopro BM) sold 2,000 shares of Ecopro BM Co Ltd (247540 KS) at 254,000 won per share.
  • It was also recently announced that Eroom T&C, the family company of Lee Dong-Chae, the chairman of Ecopro Group, also sold shares of Ecopro BM.
  • Recent selling of Ecopro BM shares by CEO Choi Mun-Ho and Ecopro affiliate Eroom T&C are negative signs on the Ecopro BM. Lofty valuations are also negative on Ecopro BM. 

EQD | Volatility Update: Weekly Review of Vol Changes and Best Trades- Peak Rates?

By Simon Harris

  • Weekly summary of vol changes and moves across Global Markets
  • Analysing ATM volatility and skew changes over the last 5 days
  • We suggest a few trades to take advantage of the implied vol surfaces

BNC Korea (256840 KS): Margin Pressure; Base Business Faces Regulatory Risk; COVID Drug in Doldrum

By Tina Banerjee

  • During 2022, BNC Korea (256840 KS) reported gross profit margin of 48.3%, lower than 51.9% reported in 2021, as increasing competition is leading to price erosion of botulinum toxin products.
  • In March 2023, prosecutors have indicted BNC Korea for allegedly selling botulinum toxin injections to exporters without the approval of the MFDS from December 2015 to December 2021.
  • With the pandemic on a downward trend for more than a year now, we are skeptical about BNC Korea’s in-licensed COVID-19 drug candidate for a milestone payment of $15M.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars